The revenue of IMMUNITYBIO, INC. over the past 10 years
Chart IMMUNITYBIO, INC.: revenue, fiscal 2016–2025 Open the chart →IMMUNITYBIO, INC. reported revenue of $113.29M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $44K — up 257373% over 9 years. Year over year, revenue rose 7 times and fell twice. The largest one-year move was in fiscal 2019: up 4585%, from $47K to $2.2M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $113.29M |
| 2024ended Dec 31, 2024 | $14.74M |
| 2023ended Dec 31, 2023 | $622K |
| 2022ended Dec 31, 2022 | $240K |
| 2021ended Dec 31, 2021 | $934K |
| 2020ended Dec 31, 2020 | $605K |
| 2019ended Dec 31, 2019 | $2.2M |
| 2018ended Dec 31, 2018 | $47K |
| 2017ended Dec 31, 2017 | $45K |
| 2016ended Dec 31, 2016 | $44K |
Fiscal years as IMMUNITYBIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IMMUNITYBIO, INC.
- The profitability of IMMUNITYBIO, INC.
- The cash flow of IMMUNITYBIO, INC.
- The debt of IMMUNITYBIO, INC.
- All of IMMUNITYBIO, INC.'s financials, charted
Companies of a similar size
- BRXBrixmor Property Group Inc.
- TTMITTM TECHNOLOGIES, INC.
- REXRRexford Industrial Realty, Inc.
- DBXDropbox, Inc.
- ZETAZeta Global Holdings Corp.
Not investment advice. This page shows what IMMUNITYBIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.